Literature DB >> 32807015

G-quadruplex ligands targeting telomeres do not inhibit HIV promoter activity and cooperate with latency reversing agents in killing latently infected cells.

Dorota Piekna-Przybylska1, Robert A Bambara1, Sanjay B Maggirwar2, Stephen Dewhurst1.   

Abstract

Altered telomere maintenance mechanism (TMM) is linked to increased DNA damage at telomeres and telomere uncapping. We previously showed that HIV-1 latent cells have altered TMM and are susceptible to ligands that target G-quadruplexes (G4) at telomeres. Susceptibility of latent cells to telomere targeting could potentially be used to support approaches to eradicate HIV reservoirs. However, G4 ligands also target G-quadruplexes in promoters blocking gene transcription. Since HIV promoter sequence can form G-quadruplexes, we investigated whether G4 ligands interfere with HIV-1 promoter activity and virus reactivation from latency, and whether telomere targeting could be combined with latency reversing agents (LRAs) to promote elimination of HIV reservoirs. Our results indicate that Sp1 binding region in HIV-1 promoter can adopt G4 structures in duplex DNA, and that in vitro binding of Sp1 to G-quadruplex is blocked by G4 ligand, suggesting that agents targeting telomeres interfere with virus reactivation. However, our studies show that G4 agents do not affect HIV-1 promoter activity in cell culture, and do not interfere with latency reversal. Importantly, primary memory CD4 + T cells infected with latent HIV-1 are more susceptible to combined treatment with LRAs and G4 ligands, indicating that drugs targeting TMM may enhance killing of HIV reservoirs. Using a cell-based DNA repair assay, we also found that HIV-1 infected cells have reduced efficiency of DNA mismatch repair (MMR), and base excision repair (BER), suggesting that altered TMM in latently infected cells could be associated with accumulation of DNA damage at telomeres and changes in telomeric caps.

Entities:  

Keywords:  DNA damage response; DNA repair; HIV-1 latency; TMM; latency reversing agents; telomere maintenance mechanism

Year:  2020        PMID: 32807015      PMCID: PMC7513862          DOI: 10.1080/15384101.2020.1796268

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  78 in total

1.  Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.

Authors:  Robert V Brown; Forest L Danford; Vijay Gokhale; Laurence H Hurley; Tracy A Brooks
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

2.  An intramolecular G-quadruplex structure formed in the human MET promoter region and its biological relevance.

Authors:  Jing Yan; Xiaoyang Zhao; Bo Liu; Ying Yuan; Yifu Guan
Journal:  Mol Carcinog       Date:  2015-05-06       Impact factor: 4.784

3.  Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy.

Authors:  Carolina Gutiérrez; Sergio Serrano-Villar; Nadia Madrid-Elena; Maria J Pérez-Elías; Maria Elena Martín; Coral Barbas; Javier Ruipérez; Eduardo Muñoz; Maria Angeles Muñoz-Fernández; Trevor Castor; Santiago Moreno
Journal:  AIDS       Date:  2016-06-01       Impact factor: 4.177

4.  Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Authors:  Julian H Elliott; James H McMahon; Christina C Chang; Sulggi A Lee; Wendy Hartogensis; Namandje Bumpus; Rada Savic; Janine Roney; Rebecca Hoh; Ajantha Solomon; Michael Piatak; Robert J Gorelick; Jeff Lifson; Peter Bacchetti; Steven G Deeks; Sharon R Lewin
Journal:  Lancet HIV       Date:  2015-11-17       Impact factor: 12.767

Review 5.  Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?

Authors:  Shankar Balasubramanian; Laurence H Hurley; Stephen Neidle
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

6.  Loss of HLTF function promotes intestinal carcinogenesis.

Authors:  Sumit Sandhu; Xiaoli Wu; Zinnatun Nabi; Mojgan Rastegar; Sam Kung; Sabine Mai; Hao Ding
Journal:  Mol Cancer       Date:  2012-03-27       Impact factor: 27.401

7.  Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

Authors:  Julian H Elliott; Fiona Wightman; Ajantha Solomon; Khader Ghneim; Jeffrey Ahlers; Mark J Cameron; Miranda Z Smith; Tim Spelman; James McMahon; Pushparaj Velayudham; Gregor Brown; Janine Roney; Jo Watson; Miles H Prince; Jennifer F Hoy; Nicolas Chomont; Rémi Fromentin; Francesco A Procopio; Joumana Zeidan; Sarah Palmer; Lina Odevall; Ricky W Johnstone; Ben P Martin; Elizabeth Sinclair; Steven G Deeks; Daria J Hazuda; Paul U Cameron; Rafick-Pierre Sékaly; Sharon R Lewin
Journal:  PLoS Pathog       Date:  2014-11-13       Impact factor: 6.823

8.  KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.

Authors:  João Lavrado; Hugo Brito; Pedro M Borralho; Stephan A Ohnmacht; Nam-Soon Kim; Clara Leitão; Sílvia Pisco; Mekala Gunaratnam; Cecília M P Rodrigues; Rui Moreira; Stephen Neidle; Alexandra Paulo
Journal:  Sci Rep       Date:  2015-04-08       Impact factor: 4.379

9.  Metastases suppressor NM23-H2 interaction with G-quadruplex DNA within c-MYC promoter nuclease hypersensitive element induces c-MYC expression.

Authors:  Ram Krishna Thakur; Praveen Kumar; Kangkan Halder; Anjali Verma; Anirban Kar; Jean-Luc Parent; Richa Basundra; Akinchan Kumar; Shantanu Chowdhury
Journal:  Nucleic Acids Res       Date:  2008-11-25       Impact factor: 16.971

10.  U3 region in the HIV-1 genome adopts a G-quadruplex structure in its RNA and DNA sequence.

Authors:  Dorota Piekna-Przybylska; Mark A Sullivan; Gaurav Sharma; Robert A Bambara
Journal:  Biochemistry       Date:  2014-04-15       Impact factor: 3.162

View more
  2 in total

Review 1.  G-Quadruplexes in Neurobiology and Virology: Functional Roles and Potential Therapeutic Approaches.

Authors:  Jinglei Xu; Haiyan Huang; Xiang Zhou
Journal:  JACS Au       Date:  2021-11-22

Review 2.  Major Achievements in the Design of Quadruplex-Interactive Small Molecules.

Authors:  Eduarda Mendes; Israa M Aljnadi; Bárbara Bahls; Bruno L Victor; Alexandra Paulo
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.